- 254. Going Public via SPACs and PIPEs, The First Mover in Ridesharing That Lost to Uber, and Building the Online Marketplace for Used Cars, Shift (George Arison)
- 253. The Changing “Search Image” of Founders, Lack of Diversity = Missed Opportunity, and COVID Effects on the BLM Movement in Europe (Eric Collins)
- 252. Decentralization of VC, Why Your Fund Size is Your Strategy, and Why Startup Formation is the Most Important Contributor to Economic Growth (Erik Torenberg)
- 251. Funding the Misunderstood Technical Founder, Self Evaluation as a Solo Capitalist, and Capital to Underwrite R&D risk vs. S&M risk (Farooq Abbasi)
- 250. Industrial Innovation, Where Blitzscaling Doesn’t Work, Why Sector Focus Wins, and Beginning with the End in Mind (Ty Findley)
- 249. Common Traits Shared by Top GPs, Why Underrepresented Fund Managers Will Produce Superior Returns, and SPACs vs. Direct Listings vs. IPOs (Lo Toney)
- 248. Scaling Rackspace, The Evolving Responsibilities of a Venture-Backed CEO, and Confronting Big Tech Monopolies (Lanham Napier)
- 247. Leaving Kleiner Perkins to Start Defy Partners, The State of Venture in the Bay Area, and Maintaining a Beginner’s Mind (Trae Vassallo)
- 246. Agglomerators vs. Specialists, the Rise of the Solo-Capitalist, and the Importance of Founder-Investor Fit (Nikhil Basu Trivedi)
- 245. Backing from Bezos, Zuckerberg, and Gates; Lessons from Reid Hoffman; and Building a Network-centric Venture Firm (Ben Casnocha)
- 244. Cross-Border Startup Expansion — Lessons from 175 Companies (Stephen McIntyre)
- 243. A Quantitative Approach to PMF, Tribe’s 8 Ball for Objective Evaluation, and Approaches to Reduce Talent Biases (Jonathan Hsu)
- 242. Structural Disadvantages in Venture, Investing in the “Overlooked,” and Open-Sourcing the VC Fund Raise and Investment Playbook (Check Warner)
- 241. Finding Markets with Long-Term Tailwinds; Macro Impacts on Venture; and Robust vs. Fragile Data (Niki Pezeshki)
- 240. Blazing Fast Path to $B+; Binary Outcomes; The Fintech Revolution; and A New Approach to Employee Comp (Henrique Dubugras)
- 239. What’s Next in Gaming; The True Essence of Product-Market-Fit; & Investing with an Emphasis on Retention and Engagement (Gigi Levy-Weiss)
- 238. GP and LP Alignment, Challenges for Emerging Fund Managers, and How the Explosion in Seed Fund Volume Plays Out (Jaclyn Hester)
- 237. Advice for Founders — Reaching out to VCs, Pitching over Zoom, and Closing Capital Amidst a Pandemic (Nick Rishwain, Hannah Konitshek, Nick Moran)
- 236. The Four Fundamentals of Investing; the Future of Micro Mobility; and Hunting Consumer Unicorns (Shawn Carolan)
- 235. Why Corporate VC Gets a Bad Wrap; Microsoft’s Fresh Approach to CVC; and Key Insights to Acquire Mass Users (Tamara Steffens)
- 234. Breaking into VC; Excelling at Goldman Sachs; and the Origin of BLCK VC (Brian Hollins)
- 233. Investment Decision in < 3 weeks; the Challenges and Opportunities with 3D Printing; and the Future for Industrial Automation (Kane Hsieh)
- 232. Network Effects; 9 Days Until a Funding Decision; Software as the Foundation for the Modern VC firm; and the Future of Social Media (James Currier)
- 231. Crisis Coverage w/ Ramy Adeeb – Why Facebook Should be Broken Up; SV Hype vs Returns; Amara’s Law; and VC’s Track Record Predicting Trends
- 230. Crisis Coverage w/ David Rabie – Finding PMF, Raising Series B, and Navigating a Startup Amidst the Pandemic
- 229. Racism in Venture — A White, Male VC Threatens Black & Brown Founders (featuring Taranvir Johal & Salman Elmi)
- 228. Crisis Coverage w/ Jim Douglass – Pandemic Effects on B2B SaaS and Healthcare — Total $ Invested, Multiples, and the Exit Environment
- 227. Crisis Coverage w/ Melody Koh – Super-Technologies; The Everyday Economy; The Overlooked Working Class; and Fear of Missing Out vs. Fear of Looking Dumb
- 226. Crisis Coverage w/ Jeff Fluhr – Launching StubHub During the Dotcom Crash; Why Market Need Trumps Market Timing; Choosing B2B vs. B2C; and Why Founders Shouldn’t Let VCs Decide Their Fate
- 225. Crisis Coverage w/ Sarah Tavel – Consumer Marketplace Investing; Why Aggregate GMV is a Red Herring; and Minimum Viable Happiness as the Key to Market Leadership
- 224. Crisis Coverage w/ Beezer Clarkson – Platform LP; Allocations in a Down-Market; COVID Strategy Drift; and Emerging Manager Selection
- 223. Crisis Coverage w/ Byron Deeter – Why This is the Seminal Moment for Cloud and Lessons from 19 Unicorn Investments
- 222. Crisis Coverage w/ Leah Solivan – Building TaskRabbit in a Recession; COVID Effects on the Independent/Gig Economy; and Key Factors for Early-Stage Marketplace Success
- 221. Crisis Coverage w/ Grace Isford – GTM Playbook; Building a Career in VC; Societal Challenges and Opportunities Post-COVID; and a Comprehensive Analysis of Successful GPs and Venture Investments
- 220. Crisis Coverage w/ Ash Fontana – The AI Investing Playbook; Why “Dev Tools” for Data Scientists is the Next Great Opportunity; When Fund Returns Don’t Fit the Power Law; and Ash’s Favorite Investment Heuristic from Naval Ravikant
- 219. Crisis Coverage w/ Tomasz Tunguz – SaaS Strategies, Sector Data, and the $ Ceiling for Deals over Zoom
- 218. Crisis Coverage w/ Richard Kerby – Tactical Advice for Raising VC Fund 1, Why Not to “Raise the Bar,” and a Framework for Startups Adjusting to COVID-19
- 217. Crisis Coverage w/ Elizabeth Yin – Investing After 1 Zoom Meeting, 2nd & 3rd Order Effects of The Virus, and Why “Market Pull” is Critical
- 216. Crisis Coverage w/ Patrick Gallagher – VC Firm Survival, How Seed Investing Scales, & A Glimpse at the Road Ahead
- 215. Crisis Coverage w/ Darren Bechtel – The Built World & Construction Tech, Post-Pandemic
- 214. Crisis Coverage w/ Somesh Dash – Late Stage Impacts & Prioritizing Mental Health
- 213. Crisis Coverage w/ Semil Shah – VC Fund Management in a Pandemic World
- 212. Crisis Coverage w/ Samir Kaji – Relief $ for Startups via CARES Act, EIDL, PPP; & How an Extended Downturn Affects Emerging VC Funds
- 211. Crisis Coverage w/ David Horowitz – How Will Corporate VC Respond?
- 210. Crisis Coverage w/ Chris Douvos – LP Lessons from ’01 and ’08, The Denominator Effect, Capital Calls & Fundraising in a Down Market
- 209. Crisis Coverage w/ Steve Blank – The Playbook for Startup Survival
- 208. Pre-Crisis Chat w/ Mark Suster – Building a VC Franchise; The Shift to Bite-Sized Video Content; Last-Mile Attribution; and The Impact of Corona Virus Over The Next 6-12 Months (Mark Suster)
- 207. Breaking Convention, Hitting The Fundraise Wall & Why Deep-tech Is Not More Capital Intensive Than Software (Ryan Gembala)
- 206. The Ultimate Testing Framework (Alex Osterwalder)
- 205. Unicorn vs Pegasus, The Softbank Effect, & Impacts of a Recession on VC (Jason Calacanis)
- 204. Embracing Failure, Capitalizing on Crisis & Building Resilience (Minnie Ingersoll)
- 203. Raising Fund III, A Framework to De-risk Your Startup, & When to Explore vs. Exploit (Leo Polovets)
- 202. Cram Session, Episodes 138-143 (Nick Moran)
- 200. University-Affiliated Funds & Angel Networks (Jason Whitney)
- 199. SPV’s, Side Cars, & The Syndication Surge (Jeremy Neilson)
- 198. Streaming Wars, The Future of Mobile & The Evolution of User Interaction (M.G. Siegler)
- 197. The DNA of Startup Success (John Vrionis)
- 196. Creating Unfair Advantages, Surviving Founder Burnout and Driving Successful Exits (Courtney Reum)
- 195. Flip The Script & Perfect Your Pitch (Oren Klaff)
- 194. Special Edition! The Story behind TFR & New Stack Ventures (John Gannon interviews Nick Moran)
- 193. SaaS Acceleration, Sales Savvy Founders & the Rise of Tech-Enabled Services (Michael Cardamone)
- 192. Secrets of Sand Hill Road (Scott Kupor)
- 191. Corporate VC (David Horowitz)
- 190. Immigration, Privacy, and Foreign Investment — The Biggest Threat to Venture is in Washington D.C. (Bobby Franklin)
- 189. The Venture Studio (Scott Dorsey)
- 188. Opportunity Zones — A Fit for VC? (Steve Glickman)
- 187. Transformative Tech for Old World Industry (Jim Kim)
- 186. Seed Investing at the Intersection of Biology & Technology (Jenny Rooke)
- 185. “Blessed” Teams, Pseudo Deal Leads, and Caps at Pre vs Post (Ash Rust)
- 184. Iconic Companies, Frontier Markets & A Truly Founder Centric Approach (Aydin Senkut)
- 183. Automation vs. AI (Adeyemi Ajao)
- 182. Market Cycles, Escalating Costs to Start Up, and the Micro VC Surge (Jeff Clavier)
- 181. Cram Session, Episodes 130-136 (Nick Moran)
- 180. The Self-Made Engineer, Angel, and Venture Capitalist (Cyan Banister)
- 179. Sales Mastery & Storytelling at Scaling Startups (Craig Wortmann)
- 178. The Gen-Z Consumer, Real-Time Health Data, and Persistent Top Fund Returns (Cheryl Cheng)
- 177. Cram Session, Episodes 121-128 (Nick Moran)
- 176. Creating Powerful Networks, 3 Rules for Great Products, and the Future of Mobile Tech (SC Moatti)
- 175. From Operator to Accelerator MD to Fund Manager (John Fein)
- 174. VCs Ride the Bus, Comeback Cities & Unorthodox Investing (Roy Bahat)
- 173. Corruption, Extortion and the Fight Against Entrenched Interests– How a VC Saves Startups from Death by Politics (Bradley Tusk)
- 172. Growth Investing in Biotech, Genomics and Pharma (Jim Tananbaum)
- 171. Sports Tech and the Future of eSports (Wayne Kimmel)
- 170. Go-to-Market Fit, Tidal Waves, Category Leadership & Split-Personalities (Tae Hea Nahm)
- 169. Product is Paramount (Brian Ascher)
- 168. Leadership from Origin to Scale (Carter Cast)
- 167. Cram Session, Episodes 113-119 (Nick Moran)
- 166. Techstars: What Worked, What Didn’t, What’s Next (David Cohen)
- 165. AV, Mobility, and the Disruption of Big Auto (Evangelos Simoudis)
- 164. The Cat and Mouse Game of Cyber Security — Israel, CISOs, and GDPR (Yoav Leitersdorf)
- 163. The ‘Softbank Effect’, Financial Discipline and the Interworkings of a Top Seed Firm (Joe Medved)
- 162. LP Value Creation, Why DPI is King, and Secondaries as a Means of Exit (Sarah Anderson)
- 161. Why SaaS is not a fit for VC and How AI Compounds Competitive Advantage (Ash Fontana)
- 160. Cram Session, Episodes 105-111 (Nick Moran)
- 160. Better Diversity, Better Outcomes (Elizabeth Galbut)
- 159. The Pioneer of Post-Seed (Paul Martino)
- 158. The Deep Tech Debate: Why Invest in a Capital Intensive, Long Time-to-Exit Category? (James Hardiman)
- 157. Leveraged Growth, the Consumer Echo Chamber & Customer Obsession (Rebecca Kaden)
- 156. Chaos Capital, the new Micro VC Movement and LPs Chasing Hype (Chris Douvos)
- 155. Predicting Technology Shifts Before they Happen (Tim O’Reilly)
- 154. NEA’s Investment Process & The Key Ingredients for Startup Success (Ben Narasin)
- 153. How Experimentation Empowers Vision & How Corporates Create an Innovation Culture (Eric Ries)
- 152. Cram Session, Episodes 96-103 (Nick Moran)
- 151. Kingmaking, De-Risking Every Investment & the Future of Real Estate Tech (Brendan Wallace)
- 150. From Running a VC Firm to Running for Governor (J.B. Pritzker)
- 149. Startup Moats, Deep Tech & Where Science Fiction becomes Science Fact (Bilal Zuberi)
- 148. New Founders, New Stages, New Offerings– The Only Constant in Venture is Change (Vic Pascucci)
- 147. Monetization Strategy & Why Price Trumps Product (Madhavan Ramanujam)
- 146. Investing in Rocket Ships Before they Take Off (Zach Coelius)
- 145. 1st Institutional VC Fund Raised– Key Learnings (Semil Shah)
- 144. The 8 Startup Profiles & Those that Make for the Strongest Investments (Guy Turner)
- 143. Beacon: Modernizing the VC Firm, Part 2 (Chris Farmer)
- 142. Beacon: An Engineering Systems Approach to Investing, Part 1 (Chris Farmer)
- 141. Cram Session, Episodes 87-94 (Nick Moran)
- 140. Navigating the Future of IoT (Panel Discussion)
- 139. How to Angel Invest like the Best, Part 2 (Jason Calacanis)
- 138. How to Angel Invest Like the Best, Part 1 (Jason Calacanis)
- 137. Cram Session, Episodes 79-85 (Nick Moran)
- 136. Dispelling Conventional Wisdom in VC, Part 2 | Should Seed Investors Follow-on? (Eric Paley)
- 135. Dispelling Conventional Wisdom in VC, Part 1 | Does Capital Drive Outcomes? (Eric Paley)
- 134. The Importance of Storytelling, VC EQ, and the LP-GP Dating Game, Part 2 (James R. ‘Trey’ Hart III)
- 133. The Importance of Storytelling, VC EQ, and the LP-GP Dating Game, Part 1 (James R. ‘Trey’ Hart III)
- 132. Nick Moran is Interviewed on Bootstrapping in America
- 131. How Amazon, Fitbit & Snap Won; Where Apple, Pebble & Google Did Not, Part 2 (Ben Einstein)
- 130. How Amazon, Fitbit & Snap Won; Where Apple, Pebble & Google Did Not, Part 1 (Ben Einstein)
- 129. Cram Session, Episodes 73-78 (Nick Moran)
- 128. Sector & Niche Focused Funds, p2 and Driving Value with a Regulatory Focus (Jordan Nof)
- 127. Sector & Niche Focused Funds, Part 1 (Jordan Nof)
- 126. Cram Session, Episodes 67-72 (Nick Moran)
- 125. Space Tech Investing, Part 2 (David Cowan)
- 124. Space Tech Investing, Part 1 (David Cowan)
- 123. Cram Session, Episodes 61-66 (Nick Moran)
- 122. Customer-centric Startup Investing Down Under, Part 2 (Niki Scevak)
- 121. Customer-centric Startup Investing Down Under, Part 1 (Niki Scevak)
- 120. Cram Session, Episodes 55-60 (Nick Moran)
- 119. Economic Theory in Venture Capital, Part 2 (Mark Suster)
- 118. Economic Theory in Venture Capital, Part 1 (Mark Suster)
- 117. Index Investing, Mastering Dealflow & Seeing Everything at Series A, Part 2 (Galen Mason & Brian Axelrad)
- 116. Index Investing, Mastering Dealflow & Seeing Everything at Series A, Part 1 (Galen Mason & Brian Axelrad)
- 115. Cram Session, Episodes 50-54 (Nick Moran)
- 114. The Next Great Startup Ecosystem is… Part 2 (Chris Olsen)
- 113. The Next Great Startup Ecosystem is… Part 1 (Chris Olsen)
- 112. Cram Session, Episodes 46-49 (Nick Moran)
- 111. Developer Platform Investing, Part 2 (Ethan Kurzweil)
- 110. Developer Platform Investing, Part 1 (Ethan Kurzweil)
- 109. Cram Session, Episodes 41-44 (Nick Moran)
- 108. Reinventing Venture Capital, Part 2 (Bryce Roberts)
- 107. Reinventing Venture Capital, Part 1 (Bryce Roberts)
- 106. Underserved Startup Ecosystems, Part 2 (Stuart Larkins & Ezra Galston)
- 105. Underserved Startup Ecosystems, Part 1 (Stuart Larkins & Ezra Galston)
- 104. Cram Session, Episodes 37-40 (Nick Moran)
- 103. The Limited Partner, Part 2 (Lindel Eakman)
- 102. The Limited Partner, Part 1 (Lindel Eakman)
- 101. The Man Behind the Mic, Part 2 (Nick Moran interviewed by Colin Keeley)
- 100. The Man Behind the Mic, Part 1 (Nick Moran interviewed by Colin Keeley)
- 99. Public Policy for Angel Investors, Part 2 (David Verrill)
- 98. Public Policy for Angel Investors, Part 1 (David Verrill)
- 97. Student-Focused VC Funds, Part 2 (Peter Boyce II)
- 96. Student-Focused VC Funds, Part 1 (Peter Boyce II)
- 95. Q&A – Nick Answers Questions from the Listeners (Nick Moran)
- 94. What’s Wrong with Venture? Part 2 (Dave McClure)
- 93. What’s Wrong with Venture? Part 1 (Dave McClure)
- 92. Cram Session, Episodes 32-36 (Nick Moran)
- 91. SpaceX & Elon Musk’s Mission to Mars, Part 2 (Tim Urban)
- 90. SpaceX & Elon Musk’s Mission to Mars, Part 1 (Tim Urban)
- 89. Cram Session, Episodes 26-31 (Nick Moran)
- 88. Fintech Investing, Part 2 (Sheel Mohnot)
- 87. Fintech Investing, Part 1 (Sheel Mohnot)
- 86. Cram Session, Episodes 18-21 (Nick Moran)
- 85. The Cap Table, Part 2 (John Buttrick & Sean Moran)
- 84. The Cap Table, Part 1 (John Buttrick & Sean Moran)
- 83. Cram Session, Episodes 11-17 (Nick Moran)
- 82. Getting Smart on a New Market, Part 2 (Charles Hudson)
- 81. Getting Smart on a New Market, Part 1 (Charles Hudson)
- 80. Hardware Investing, Part 2 (Avidan Ross)
- 79. Hardware Investing, Part 1 (Avidan Ross)
- 78. Artificial Intelligence Investing, Part 2 (Nathan Benaich)
- 77. Artificial Intelligence Investing, Part 1 (Nathan Benaich)
- 76. No Fun Allowed, Part 2 (Jonathon Triest & Brett DeMarrais)
- 75. No Fun Allowed, Part 1 (Jonathon Triest & Brett DeMarrais)
- 74. Virtual Reality Investing, Part 2 (Adam Draper)
- 73. Virtual Reality Investing, Part 1 (Adam Draper)
- 72. Blockchain Investing, Part 2 (William Mougayar)
- 71. Blockchain Investing, Part 1 (William Mougayar)
- 70. Building an Investor Brand, Part 2 (Jay Acunzo & John Gannon)
- 69. Building an Investor Brand, Part 1 (Jay Acunzo & John Gannon)
- 68. The Bloomberg for Private Companies, Part 2 (Anand Sanwal)
- 67. The Bloomberg for Private Companies, Part 1 (Anand Sanwal)
- 66. From Angel Group to Venture Fund, Part 2 (Maia Heymann)
- 65. From Angel Group to Venture Fund, Part 1 (Maia Heymann)
- 64. The Fast No, Part 2 (Mike Collett)
- 63. The Fast No, Part 1 (Mike Collett)
- 62. Diversity in Venture Capital, Part 2 (Christine Tsai)
- 61. Diversity in Venture Capital, Part 1 (Christine Tsai)
- 60. Algorithm-Based Investing, Part 2 (Andrew Parker)
- 59. Algorithm-Based Investing, Part 1 (Andrew Parker)
- 58. Startup Boards, Part 2 (Mahendra Ramsinghani)
- 57. Startup Boards, Part 1 (Mahendra Ramsinghani)
- 56. The Hands-on Investor | High-Engagement Investing, Part 2 (John Greathouse)
- 55. The Hands-on Investor | High-Engagement Investing, Part 1 (John Greathouse)
- 54. The Path to Series A, Part 2 (Semil Shah)
- 53. The Path to Series A, Part 1 (Semil Shah)
- 52. The Hunt for Investors, Part 2 (Mark Peter Davis)
- 51. The Hunt for Investors, Part 1 (Mark Peter Davis)
- 50. The 3-year Wait is Over | SEC Vote on JOBS Act Title III (David S. Rose)
- 49. The Value of Data, Part 2 (Leo Polovets)
- 48. The Value of Data, Part 1 (Leo Polovets)
- 47. Founder-Investor Fit (Peter Wilkins)
- 46. The Must-Have Characteristics of SaaS Startups (Tomasz Tunguz)
- 45. Angel Best Practices #6 | The Deal (Nick Moran)
- 44. Negotiating a Term Sheet (Jason Heltzer)
- 43. Why Angels Don’t Do Drugs | Life Sciences Investing (Sergio Gurrieri)
- 42. Raising a VC Fund (Jonathan Struhl)
- 41. The Exit (John Huston)
- 40. Crowdfunding & The Socialization of Finance (Jon Medved)
- 39. Cleantech Investing (Rob Day)
- 38. Cross-Border Investing (Michael Goldberg)
- 37. The Algorithm for Raise Amount & Valuation (Leo Polovets)
- 36. SaaS Startup Investing (Mamoon Hamid)
- 35. Developing Startup Ecosystems & High-Touch Screening (Eric Gasser)
- 34. Lone-Wolves vs VC’s vs Angel Groups vs Syndicates (Nick Moran)
- 33. AngelList Syndicate Investing (Gil Penchina)
- 32. Capital Outside of the Valley (Morris Wheeler, Mike Belsito)
- 31. The Pitch (David Brown)
- 30. The Dark Side of VC | Predatory Investor Practices (Joanne Wilson)
- 29. Angel Best Practices #5 | Evaluating the Product & the Market (Nick Moran)
- 28. The Investment Readiness Level (Steve Blank)
- 27. Angel Best Practices #4 | Evaluating the Team (Nick Moran)
- 26. A New Era of Startup Investing | Angel Evolution (Christopher Mirabile)
- 25. Angel Best Practices #3 | Deal-Flow (Nick Moran)
- 24. Angel Best Practices #2 | Strategy (Nick Moran)
- 23. Angel Best Practices #1 | Intro & Overview (Nick Moran)
- 22. Lessons from 5 Years of Angel Investing (Gabriel Weinberg)
- 21. VC Portfolio Strategy (Rob Go)
- 20. Non-Unicorn Investing (Jerry Neumann)
- 19. Due Diligence (Imran Ahmad)
- 18. Fundraise Types, Sources & Structures (Dave Berkus)
- 17. The Accelerator (Troy Henikoff)
- 16. Venture in the Media (Erin Griffith)
- 15. Cram Session Episodes 1-10 (Nick Moran)
- 14. The Stages of Fundraising (Ann Winblad)
- 13. The Convertible Note (Bill Payne)
- 12. Advising Early-Stage Startups (Glenn Gottfried)
- 11. The #1 Reason Startups Fail (Gabriel Weinberg)
- 10. The Term Sheet (Brad Feld)
- 9. Valuation p2, Ethics & Midwest Venture (Jeffrey Carter)
- 8. Valuation, Part 1 (Jeffrey Carter)
- 7. Angel Groups (Michael Gruber)
- 6. Dealflow (Charlie O’Donnell)
- 5. Evaluating Startups for Investment (George Deeb)
- 4. The Startup Ecosystem “Key players” (Howard Tullman)
- 3. Angel Investing 101 (David S. Rose)
- 2. Venture Capital — Funds, Angels & Entrepreneurs (Chris Yeh)
- 1. The Black Box of Venture Capital (Nick Moran)
Investor Stories
- Investor Stories 163: Strange & Unusual (Warner, Adeeb, Gallagher, Carolan)
- Investor Stories 162: Lessons Learned (Kerby, Hester, Napier, Blank)
- Investor Stories 161: What’s Next (Hsu, Vrionis, Vassallo, Hsieh)
- Investor Stories 160: Why I Passed (Bechtel, Koh, Dash, Fluhr)
- Investor Stories 159: Post Mortems (Ingersoll, Douglass, Siegler, Currier)
- Investor Stories 158: Strange & Unusual (Yin, Cardamone, Levy-Weiss, Pezeshki)
- Investor Stories 157: Lessons Learned (Dubugras, Gembala, Isford, Kupor)
- Investor Stories 156: What’s Next (Whitney, Carolan, Horowitz, Hester)
- Investor Stories 155: Why I Passed (Klaff, Steffens, Polovets, Deeter)
- Investor Stories 154: Post Mortems (Clarkson, Osterwalder, Gallagher, Blank)
- Investor Stories 153: Strange & Unusual (Solivan, Hsieh, Kerby, Currier)
- Investor Stories 152: Lessons Learned (Reum, Suster, Tavel, Calacanis)
- Investor Stories 151: What’s Next (Adeeb, Dash, Neilson, Ingersoll)
- Investor Stories 150: Why I Passed (Siegler, Isford, Vrionis, Rust)
- Investor Stories 149: Post Mortems (Gembala, Dorsey, Yin, Fluhr)
- Investor Stories 148: Strange & Unusual (Kupor, Koh, Tunguz, Douglass)
- Investor Stories 147: Lessons Learned (Osterwalder, Clarkson, Cardamone, Polovets)
- Investor Stories 146: What’s Next (Gallagher, Tavel, Deeter, Kim)
- Investor Stories 145: Why I Passed (Ingersoll, Ajao, Kerby, Horowitz)
- Investor Stories 144: Post Mortems (Solivan, Klaff, Whitney, Bechtel)
- Investor Stories 143: Strange & Unusual (Isford, Dash, Blank, Suster)
- Investor Stories 142: Lessons Learned (Vrionis, Yin, Franklin, Neilson)
- Investor Stories 141: What’s Next (Gembala, Rooke, Clavier, Reum)
- Investor Stories 140: Why I Passed (Osterwalder, Kupor, Cheng)
- Investor Stories 139: Post Mortems (Cardamone, Kim, Calacanis)
- Investor Stories 138: Strange & Unusual (Ingersoll, Dorsey, Siegler)
- Investor Stories 137: Lessons Learned (Senkut, Glickman, Rust)
- Investor Stories 136: What’s Next (Ajao, Klaff, Polovets)
- 135. Investor Stories CRAM Session: Why I Passed (Struhl, Greathouse, Wilson, Shah, Roberts, Henikoff, Heltzer, Mirabile, Brown, Feld)
- Investor Stories 134: Post Mortems (Vrionis, Horowitz, Banister)
- Investor Stories 133: Strange & Unusual (Neilson, Whitney, Rooke)
- Investor Stories 132: Lessons Learned (Dorsey, Clavier, Fein)
- Investor Stories 131: What’s Next (Kupor, Cardamone, Siegler)
- Investor Stories 130: Why I Passed (Kim, Reum, Senkut)
- Investor Stories 129: Post Mortems (Ajao, Rust, Moatti)
- Investor Stories 128: Strange & Unusual (Vrionis, Tusk, Klaff)
- Investor Stories 127: Lessons Learned (Wortmann, Horowitz, Banister)
- Investor Stories 126: Whats Next (Franklin, Glickman, Cheng)
- Investor Stories 125: Why I Passed (Cardamone, Rooke, Dorsey)
- Investor Stories 124: Post Mortems (Clavier, Tusk, Kupor)
- Investor Stories 123: Strange & Unusual (Horowitz, Kim, Rust)
- Investor Stories 122: Lessons Learned (Ajao, Bahat, Cheng)
- Investor Stories 121: What’s Next (Dorsey, Senkut, Banister)
- Investor Stories 120: Why I Passed (Hea Nahm, Moatti, Clavier)
- Investor Stories 119: Special Edition! Why I Invested in Curv Labs (Moran, Balish, Deshays)
- Investor Stories 118: Strange & Unusual (Glickman, Wortmann, Fein)
- Investor Stories 117: Lessons Learned (Tusk, Kim, Rooke)
- Investor Stories 116: What’s Next (Bahat, Rust, Kimmel)
- Investor Stories 115: Post Mortems (Senkut, Fein, Cheng)
- Investor Stories 114: Strange & Unusual (Ajao, Banister, Clavier)
- Investor Stories 113: Lessons Learned (Tananbaum, Ascher, Nahm)
- Investor Stories 112: Special Edition! Why I Invested in Winston Privacy (Moran, Stokes, Dwyer)
- Investor Stories 111: What’s Next (Wortmann, Moatti, Tusk)
- Investor Stories 110: Why I Passed (Banister, Cohen, Fein)
- Investor Stories 109: Post Mortems (Kaden, Bahat, Galbut)
- Investor Stories 108: Strange & Unusual (Simoudis, Cheng, Kimmel)
- Investor Stories 107: Lessons Learned (Moatti, Wallace, Pascucci)
- Investor Stories 106: What’s Next (Tananbaum, Fein, Anderson)
- Investor Stories 105: Why I Passed (Tusk, Bahat, Ascher)
- Investor Stories 104: Lessons Learned (Fontana, Kimmel, Farmer)
- Investor Stories 103: Post Mortems (Nahm, Cohen, Leitersdorf)
- Investor Stories 102: Strange & Unusual (Olsen, Hardiman, Galbut)
- Investor Stories 101: Lessons Learned (Kaden, Duovos, Cast)
- Investor Stories 100: Why I Passed (Wallace, Zuberi, Medved)
- Investor Stories 99: Post Mortems (Martino, Simoudis, Narasin)
- Investor Stories 98: The Strange & Unusual (Anderson, O’Reilly, Pascucci)
- Investor Stories 97: Lessons Learned (Einstein, Cohen, Nof)
- Investor Stories 96: What’s Next (Ascher, Medved, Fontana)
- Investor Stories 95: Why I Passed (Kaden, Hardiman, Simoudis)
- Investor Stories 94: The Strange & Unusual (Ramanujam, Turner, Leitersdorf)
- Investor Stories 93: Lessons Learned (Zuberi, Coelius, Galbut)
- Investor Stories 92: What’s Next (Martino, Calacanis, Farmer)
- Investor Stories 91: Why I Passed (Anderson, Fontana, Duovos)
- Investor Stories 90: Post Mortems (Wallace, Shah, Medved)
- Investor Stories 89: The Strange & Unusual (Farmer, Kaden, Narasin)
- Investor Stories 88: Lessons Learned (Hardiman, Benaich, Martino)
- Investor Stories 87: What’s Next (Nof, Olsen, Galbut)
- Investor Stories 86: My Investing Strategy (Roberts, Collett, Scevak)
- Investor Stories 85: Why I Passed (Pascucci, Einstein, Kurzweil, Verrill)
- Investor Stories 84: Post Mortems (Zuberi, Ramanujem, O’Reilly)
- Investor Stories 83: The Strange & Unusual (Eakman, Douvos, Shah)
- Investor Stories 82: Lessons Learned (Mohnot, Turner, Narasin)
- Investor Stories 81: What’s Next (Pascucci, Wallace, Kaden)
- Investor Stories 80: My Investing Strategy (Boyce, Nof, Gurrieri)
- Investor Stories 79: Why I Invested (Farmer, Olsen, Cowan)
- Investor Stories 78: Why I Passed (Coelius, Benaich, Calacanis)
- Investor Stories 77: The Strange & Unusual (Larkins & Galston, Einstein, Zuberi)
- Investor Stories 76: What’s Next (Turner, Triest & DeMarrais, Mougayar, Ramanujam)
- Investor Stories 75: Lessons Learned (Buttrick, Shah, Paley)
- Investor Stories 74: Why I Invested (Tsai, Greathouse, Eakman)
- Investor Stories 73: Why I Passed (Draper, Farmer, Suster)
- Investor Stories 72: The Strange & Unusual (Verrill, Mason, Calacanis)
- Investor Stories 71: Lessons Learned (Parker, Scevak, Roberts, Hudson)
- Investor Stories 70: What’s Next (Einstein, Galston & Larkins, Cowan)
- Investor Stories 69: Exceptional Founders (Olsen, Acunzo, Collett)
- Investor Stories 68: My Investing Strategy (Benaich, Kurzweil, Triest & DeMarrais)
- Investor Stories 67: Why I Invested (Nof, Wilkins, Sanwal)
- Investor Stories 66: Why I Passed (Mougayar, Mohnot, Cowan)
- Investor Stories 65: Lessons Learned (Tunguz, Davis, Draper, Eakman)
- Investor Stories 64: What’s Next (Acunzo, Rose, Scevak)
- Investor Stories 63: Exceptional Founders (Boyce, Ramsinghani, Greathouse)
- Investor Stories 62: My Investing Strategy (Parker, Suster, Shah)
- Investor Stories 61: Why I Invested (Roberts, Struhl, Verrill)
- Investor Stories 60: Why I Passed (Triest & DeMarrais, Tsai, Larkins & Galston)
- Investor Stories 59: Lessons Learned (Olsen, Collett, Sanwal)
- Investor Stories 58: What’s Next (Kurzweil, Buttrick, Hudson)
- Investor Stories 57: Exceptional Founders (Wilkins, Mason, Benaich)
- Investor Stories 56: My Investing Strategy (Mohnot, Mougayar, Tunguz)
- Investor Stories 55: Why I Passed (Roberts, Heymann, Eakman)
- Investor Stories 54: Why I Invested in Regroup Therapy (Moran, Cohn, Saunders)
- Investor Stories 53: Lessons Learned (Heltzer, Larkins & Galston, McClure)
- Investor Stories 52: What’s Next (Draper, Ramsinghani, Parker)
- Investor Stories 51: Exceptional Founders (Davis, Triest & DeMarrais, Verrill)
- Investor Stories 50: My Investing Strategy (Acunzo, Rose, Hudson)
- Investor Stories 49: Why I Invested (Polovets, Collett, Benaich)
- Investor Stories 48: Why I Passed (Greathouse, Boyce, Huston)
- Investor Stories 47: Lessons Learned (Tsai, Mougayar, Shah)
- Investor Stories 46: What’s Next (Gurrieri, Wilkins, Mohnot)
- Investor Stories 45: Exceptional Founders (Parker, Tunguz, Heltzer)
- Investor Stories 44: My Investing Strategy (Buttrick, Sanwal, O’Donnell)
- Investor Stories 43: Why I Invested (Davis, Heymann, Ramsinghani)
- Investor Stories 42: Why I Passed (Struhl, Collett, Hudson)
- Investor Stories 41: Lessons Learned (Triest & DeMarrais, Polovets, Rose)
- Investor Stories 40: What’s Next (Benaich, Tsai, Carter)
- Investor Stories 39: Why I Invested (Shah, Huston, Draper)
- Investor Stories 38: Exceptional Founders (Mougayar, Medved, Tsai)
- Investor Stories 37: My Investing Strategy (Heymann, Wilkins, Day)
- Investor Stories 36: Lessons Learned (Acunzo, Greathouse, Ramsinghani)
- Investor Stories 35: Why I Invested in Tovala (Moran, Rabie, Heltzer)
- Investor Stories 34: What’s Next (Davis, Sanwal, Collett)
- Investor Stories 33: Why I Invested (Heltzer, Goldberg, Parker)
- Investor Stories 32: Exceptional Founders (Heymann, Struhl, Polovets)
- Investor Stories 31: My Investing Strategy (Ramsinghani, Tsai, Gasser)
- Investor Stories 30: Why I Invested in Cybrary (Moran, Label, Corey)
- Investor Stories 29: Why I Passed (Shah, Wilkins, Parker)
- Investor Stories 28: What’s Next (Greathouse, Medved, Huston)
- Investor Stories 27: Exceptional Founders (Shah, Gurrieri, Penchina)
- Investor Stories 26: My Investing Strategy (Davis, Carter, Struhl)
- Investor Stories 25: Why I Invested (Ahmad, Rose, Tunguz)
- Investor Stories 24: Why I Passed (Heltzer, Gurrieri, Hamid)
- Investor Stories 23: Lessons Learned (Struhl, Huston, Wilkins)
- Investor Stories 22: What’s Next (Hamid, O’Donnell, Tunguz)
- Investor Stories 21: Exceptional Founders (Wheeler, Day, Rose)
- Investor Stories 20: My Investing Strategy (Huston, Brown, Heltzer)
- Investor Stories 19: Why I Invested (Medved, Neumann, Gurrieri)
- Investor Stories 18: Why I Passed (Mirabile, Polovets, O’Donnell)
- Investor Stories 17: What’s Next (Gasser, Struhl, Day)
- Investor Stories 16: Exceptional Founders (Carter, Goldberg, Huston)
- Investor Stories 15: My Investing Strategy (Hamid, Polovets, Medved)
- Investor Stories 14: Why I Invested (O’Donnell, Blank, Day)
- Investor Stories 13: Why I Passed (Wilson, Carter, Ahmad)
- Investor Stories 12: What’s Next? (Polovets, Goldberg, Penchina)
- Investor Stories 11: Exceptional Founders (Hamid, Gasser, O’Donnell)
- Investor Stories 10: My Investing Strategy (Henikoff, Penchina, Neumann)
- Investor Stories 9: Why I Invested (Carter, Gasser, Go)
- Investor Stories 8: Why I Passed (Brown, Blank, Berkus)
- Investor Stories 7: What’s Next? (Wheeler, Blank, Wilson)
- Investor Stories 6: My Investing Strategy (Mirabile, Wheeler, Winblad)
- Investor Stories 5: Exceptional Founders (Wilson, Brown, Mirabile)
- Investor Stories 4: Why I Passed (Henikoff, Neumann, Go)
- Investor Stories 3: My Investing Strategy (Imran Ahmad, Dave Berkus, Rob Go)
- Investor Stories 2: Why I Invested (Dave Berkus, Troy Henikoff, Ann Winblad)
- Investor Stories 1: Why I Passed (Brad Feld, Ann Winblad, Gabriel Weinberg)